Viking has long been viewed as a takeover target, given the positive data from early VK2735 trials. The company’s most recent ...

Viking (VKTX) is in the midst of a phase 2a dosing trial of its oral obesity drug VK2735, with a data readout expected in the second half of the year. The company is expected to launch a phase 3 trial ...

Table 2 outlines a step-wise approach to opioid titration in dyspnea similar to ... Proper dosing is often dependent on perfect technique of these technically challenging devices.

Typically, a responsible doctor approaches prescriptions with a titration mindset ... has created a perfect storm for a more insidious problem to thrive: a flourishing counterfeit market that ...

Exciting progress is being made in animal biology and behaviour, animal health and welfare and in the management of animal communities,emerging infectious diseases, conservation, de-extinction using ...